Konruns(SH:603590) Zheng Quan Zhi Xing·2025-09-05 08:19Core Viewpoint - The major shareholder of Beijing Kangchen Pharmaceutical Co., Ltd., Liu Jianhua, plans to reduce his shareholding due to personal financial needs, with a maximum reduction of 4,780,693 shares, which is approximately 3% of the total share capital [1][2]. Shareholder Reduction Plan - Liu Jianhua holds 50,786,760 shares, representing 31.87% of the total share capital of 159,356,477 shares as of September 5, 2025 [1][2]. - The reduction will occur within three months starting from 15 trading days after the announcement, specifically from September 29, 2025, to December 28, 2025 [2]. - The reduction methods include centralized bidding and block trading, with a maximum of 1,593,564 shares through centralized bidding and 3,187,129 shares through block trading [2]. - The reduction price will be based on the market price at the time of the reduction [1]. Compliance and Previous Commitments - Liu Jianhua previously committed to not reducing his shareholding below the issue price for two years after the lock-up period, with a maximum cumulative reduction of 20% of his total shares [3]. - The current reduction plan is consistent with the commitments made in the company's initial public offering (IPO) prospectus [3]. Regulatory Compliance - The reduction plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [3]. - The company will continue to monitor the situation and fulfill its information disclosure obligations as required [3].